GlobeVerge
INDIA
U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
Read it at The HinduMore stories
- Farage dominates Clacton by-election, Binface surges and 32 others trail
- Trump orders navy to revert to steam-powered fighter launching system
- ‘Deeply flawed approach’: Bar Council’s NALSAR enrolment U-turn draws criticism from ABVP
- Caste Census 2027: Full list of questions to be asked in the second phase of Census